Placenta Market Size Worth $236.01 Million by 2032 | CAGR: 12.40%

The global placenta market size is expected to reach USD 236.01 Million by 2032, according to a new study by Polaris market research. The report “Placenta Market Share, Size, Trends, Industry Analysis Report, By Type (Porcine, Equine, Ovine, Others); By Application; By Region; Segment Forecast, 2023-2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

One of the main factors driving the placenta market is the increase in demand for skin-rejuvenating and anti-aging products. For more than a century, wound care and wound healing have been aided by the utilization of the abundant stem cells found in the placenta. A potent combination of growth factors and anti-inflammatory proteins, in particular, found in the amniotic membrane, can help the body interact with cells when it is ill or injured.

The normal function of placenta cells can be restored with the aid of regenerative drugs. Effective treatments for chronic illnesses are projected to be made possible by the field's quick improvements. For instance, mesenchymal stem cells generated from human placentas are a new alternative source of MSCs with a number of benefits, according to a research article by Yifeng Lin published in 2022. In order to further understand their therapeutic effectiveness and potential underlying mechanisms, we infused HP-MSCs with cross-linked hyaluronic acid hydrogel to optimize their retention inside the uterus.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/placenta-market/request-for-sample

One of the key drivers of market expansion is significant R&D investments. In addition, the growing need for potent treatments to lessen the burden of disease during the predicted period is another factor fueling the growth. For instance, a 2022 research study by Felor Biniazan examined the effects of the placenta based amniotic epithelial cells on wound healing process & TGF induced scar formation in a murine injury model.

For instance, according to a research study by Kirat Chand that was published in 2022, hPD-MSC therapy causes changes in metabolite and protein levels as well as serum biomarker(s) of ageing and/or rejuvenation. Surprisingly, hPD-MSC treatment boosted serotonin synthesis due to faster rates of vitamin B6 metabolism. The expression of mRNAs and proteins linked to hepatocyte proliferation and mitochondrial biogenesis was changed by elevated liver serotonin levels following repeated injection therapy. After receiving hPD-MSC therapy, metabolite changes in the blood can be used to find ageing and/or rejuvenation biomarkers. Serotonin is also an important therapeutic target for correcting liver deterioration brought on by ageing.

Placenta Market Report Highlights

• • •  
• In 2022, the Ovine dominated the whole market, accounting for major sales revenue. The rising demand for dietary supplements, medicines, and cosmetics that contain placenta extracts is to blame for the market's expansion.
• The pharmaceutical industry dominated the market, in 2022. The significant factors driving the market are an increase in clinical trials, an increase in strategic initiatives, an increase in the prevalence of chronic diseases, and improvements in healthcare services.

• • •  
• North America hold the largest revenue in 2022. The main factors driving the market include North America's robust biotechnology sector, the existence of major players, considerable R&D, and the promotion of personalized medications.
• The global players with global presence include Brroklyn Placenta Services, Atlanta Placenta, MiMedx Group, TelaGen, Thimba Li, and Agri-Labco-Products.

Polaris Market Research has segmented the Placenta Market report based on product type, application, and region:

Placenta, Type Outlook (Revenue - USD Million, 2019 - 2032)

• Porcine
• Equine
• Ovine
• Others

Placenta, Application Outlook (Revenue - USD Million, 2019 - 2032)

• Pharmaceuticals
• Cosmetics
• Supplements
• Others

Placenta, Regional Outlook (Revenue - USD Million, 2019 - 2032)

• North America

• U.S.
• Canada

• Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands

• Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia

• Latin America

• Argentina
• Brazil
• Mexico

• Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa